Michael D Green
@_Beam_On
Followers
189
Following
55
Media
0
Statuses
37
Green Lab @ Michigan | Translational Oncology
Ann Arbor, Michigan
Joined January 2021
Huge shoutout to the collaborative team from Michigan who worked on this including Gaopeng Li, Weiping Zou, and @ArulChinnaiyan ! Let us know what you think!.
0
0
0
Does immunotherapy help all cancer patients? . At least in a subset of patients and preclinical models, immune checkpoint blockade can cause hyperprogression of cancer. Paper out now in: @Cancer_Cell 👇.
3
39
146
RT @AndrewChowMDPhD: Leveraging CD39 To Identify Tumor-Reactive CD8 T cells In Human Lung Cancer (1/6).
0
20
0
RT @ChelseaPinnix: The @RadiumSociety is honored to award The Janeway Medal to @PierceLoriJ! Since 1933, ARS has sponsored a lecture in mem….
0
4
0
Beautiful translational work on how tissue resident macrophages suppress antitumor immunity by Andrew Chow and colleagues!.
A study out of Ludwig @sloan_kettering reports in @Cancer_Cell how immune cells known as macrophages in body cavities can aid tumor growth by distracting CD8+ T-cells from their anti-tumor duties using a receptor the former cells express named Tim-4.
0
0
3
RT @JSheltzer: New paper from @joans and me! A pan-cancer, cross-platform analysis identifies >100,000 genomic biomarkers for cancer outcom….
0
78
0
RT @WUSTLmed: #WashUMed radiation oncology professor @carmenbergom, MD, PhD, will receive the 2021 Michael Fry Research Award from the @RRS….
0
5
0
Well deserved, congrats to both of you!.
Karen @karenmcl13 and I started our labs at the same time @UMRogelCancer and we are promoted to Associate Professors with tenure in the same cycle. Trainees are now faculty or at IO industry! Collaboration and innovation are the cornerstones of Michigan value! Thank you @wgiannob
0
0
2
RT @LyssiotisLab: Master class in brain cancer (#GBM, #DIPG) #tumormetabolism and #radiation from @DanWahlMD, @UMichRadOnc at @UMRogelCance….
0
2
0
RT @YatrikShahLab: Find out how we can selectively kill HIF2 expressing colon cancer cells. Awesome work by @rashi_singhal7, and thanks to….
0
18
0
RT @JAMAOnc: NRG-BR001 is an NCI-sponsored phase 1 trial of SBRT for oligometastatic lesions in pts w/#BreastCancer, #ProstateCancer, or #N….
0
8
0
RT @BraunMDPhD: 1/ Happy to share our latest work out today in @Cancer_Cell – a single-cell dissection of the kidney cancer immune microenv….
0
65
0
RT @bmassutis: Acquired resistance increases over time in lung cancer treated with Anti PD-(L)1 agents @myESMO @OncoAlert #ELCC21 https….
0
16
0
Tremendous longitudinal study looking at how truly durable anti-tumor immunity can last. Congrats @cvangelesMD !.
1
0
2
Immunotherapy is changing oncology, but who benefits? In over 1000 melanoma patients treated with immune checkpoint inhibitors, the presence of liver metastases and elevations in lactate dehydrogenase were critical drivers of prognosis.
0
0
7
Great example of the power of sequencing in oncology. #goblue.
Mi-ONCOSEQ study at @UMRogelCancer identifies high rate of inherited cancer predisposition and significant benefit from targeted therapy among patients with cancer of unknown primary and other rare cancers undergoing comprehensive genomic profiling
0
0
0
RT @rweichselbaum: Radiotherapy and immunotherapy converge on elimination of tumor-promoting erythroid progenitor cells through adaptive im….
0
38
0
The Green and Morgan Labs are recruiting- technicians, scientists, and postdoctoral fellows for projects looking at t cell exhaustion, liver tolerance mechanisms, ferroptosis, and more! Please apply: Please retweet!.
0
6
13